Elucidation of the structural basis of interaction of the BCR-ABL kinase inhibitor, nilotinib (Tasigna) with the human ABC drug transporter P-glycoprotein.

ABSTRACT:

SUBMITTER: Shukla S 

PROVIDER: S-EPMC3981924 | biostudies-literature | 2014 Apr

REPOSITORIES: biostudies-literature